Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1989 Nov 4;299(6708):1127–1131. doi: 10.1136/bmj.299.6708.1127

Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study.

A Rosengren 1, L Welin 1, A Tsipogianni 1, L Wilhelmsen 1
PMCID: PMC1837993  PMID: 2513018

Abstract

OBJECTIVE--To investigate the effect of cardiovascular risk factors on coronary heart disease and all cause mortality in middle aged diabetic men. DESIGN--Prospective population study based on data collected from second screening (from 1974 to 1977) in the multifactor primary prevention trial and follow up until March 1983. SETTING--Gothenburg, Sweden. SUBJECTS--6897 Men aged 51 to 59, of whom 232 were self reported diabetics and 6665 were non-diabetic; none had a history of myocardial infarction. MAIN OUTCOME MEASURES--Incidences of coronary heart disease and mortality from all causes. RESULTS--Diabetic men with a serum cholesterol concentration greater than 7.3 mmol/l had a significantly higher incidence of coronary heart disease during follow up than those with a concentration less than or equal to 5.5 mmol/l (28.3% v 5.4%; p = 0.020); corresponding figures for non-diabetic men were 9.4% and 2.4% respectively. In multivariate logistic regression analyses serum cholesterol concentration and smoking habit were independent predictors of coronary heart disease (odds ratio serum cholesterol concentration 6.1 (95% confidence interval 2.1 to 17.6) current smoking 2.9 (1.1 to 7.5)) and of all cause mortality (3.2 (1.3 to 7.9), 3.0 (1.4 to 6.7) respectively) in diabetic men whereas systolic blood pressure, body mass index, family history, marital state, and alcohol abuse were not. Low occupational class was an independent predictor of mortality (2.4 (1.01 to 5.5)), but not of coronary heart disease, in diabetic men. CONCLUSIONS--Middle aged diabetic men with hypercholesterolaemia are at very high risk of developing coronary heart disease and of dying prematurely. Lowering serum cholesterol concentration in such subjects seems to be warranted.

Full text

PDF
1127

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett-Connor E. The prevalence of diabetes mellitus in an adult community as determined by history or fasting hyperglycemia. Am J Epidemiol. 1980 Jun;111(6):705–712. doi: 10.1093/oxfordjournals.aje.a112948. [DOI] [PubMed] [Google Scholar]
  2. Betteridge D. J. Diabetes, lipoprotein metabolism and atherosclerosis. Br Med Bull. 1989 Jan;45(1):285–311. doi: 10.1093/oxfordjournals.bmb.a072317. [DOI] [PubMed] [Google Scholar]
  3. Blankenhorn D. H., Nessim S. A., Johnson R. L., Sanmarco M. E., Azen S. P., Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987 Jun 19;257(23):3233–3240. [PubMed] [Google Scholar]
  4. Butler W. J., Ostrander L. D., Jr, Carman W. J., Lamphiear D. E. Mortality from coronary heart disease in the Tecumseh study. Long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol. 1985 Apr;121(4):541–547. doi: 10.1093/oxfordjournals.aje.a114031. [DOI] [PubMed] [Google Scholar]
  5. Elmfeldt D., Wilhelmsen L., Tibblin G., Vedin J. A., Wilhelmsson C. E., Bengtsson C. Registration of myocardial infarction in the city of Göteborg, Sweden. J Chronic Dis. 1975 Mar;28(3):173–186. doi: 10.1016/0021-9681(75)90005-3. [DOI] [PubMed] [Google Scholar]
  6. Frick M. H., Elo O., Haapa K., Heinonen O. P., Heinsalmi P., Helo P., Huttunen J. K., Kaitaniemi P., Koskinen P., Manninen V. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987 Nov 12;317(20):1237–1245. doi: 10.1056/NEJM198711123172001. [DOI] [PubMed] [Google Scholar]
  7. Fuller J. H., Shipley M. J., Rose G., Jarrett R. J., Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) 1983 Sep 24;287(6396):867–870. doi: 10.1136/bmj.287.6396.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harmsen P., Berglund G., Larsson O., Tibblin G., Wilhelmsen L. Stroke registration in Göteborg, Sweden, 1970-75. Incidence and fatality rates. Acta Med Scand. 1979;206(5):337–344. doi: 10.1111/j.0954-6820.1979.tb13524.x. [DOI] [PubMed] [Google Scholar]
  9. Harris M. I., Hadden W. C., Knowler W. C., Bennett P. H. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes. 1987 Apr;36(4):523–534. doi: 10.2337/diab.36.4.523. [DOI] [PubMed] [Google Scholar]
  10. Howard B. V., Knowler W. C., Vasquez B., Kennedy A. L., Pettitt D. J., Bennett P. H. Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Comparison of diabetics and nondiabetics. Arteriosclerosis. 1984 Sep-Oct;4(5):462–471. doi: 10.1161/01.atv.4.5.462. [DOI] [PubMed] [Google Scholar]
  11. Jarrett R. J., McCartney P., Keen H. The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia. 1982 Feb;22(2):79–84. doi: 10.1007/BF00254833. [DOI] [PubMed] [Google Scholar]
  12. Jarrett R. J., Shipley M. J. Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease--putative association via common antecedents; further evidence from the Whitehall Study. Diabetologia. 1988 Oct;31(10):737–740. doi: 10.1007/BF00274775. [DOI] [PubMed] [Google Scholar]
  13. Kannel W. B., Gordon T., Castelli W. P. Role of lipids and lipoprotein fractions in atherogenesis: the Framingham study. Prog Lipid Res. 1981;20:339–348. doi: 10.1016/0163-7827(81)90067-9. [DOI] [PubMed] [Google Scholar]
  14. Kannel W. B. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J. 1985 Nov;110(5):1100–1107. doi: 10.1016/0002-8703(85)90224-8. [DOI] [PubMed] [Google Scholar]
  15. Kannel W. B., McGee D. L. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979 May 11;241(19):2035–2038. doi: 10.1001/jama.241.19.2035. [DOI] [PubMed] [Google Scholar]
  16. Kannel W. B., McGee D. L. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979 Jan;59(1):8–13. doi: 10.1161/01.cir.59.1.8. [DOI] [PubMed] [Google Scholar]
  17. Keen H., Jarrett R. J. The WHO multinational study of vascular disease in diabetes: 2. Macrovascular disease prevalence. Diabetes Care. 1979 Mar-Apr;2(2):187–195. doi: 10.2337/diacare.2.2.187. [DOI] [PubMed] [Google Scholar]
  18. Kleinman J. C., Donahue R. P., Harris M. I., Finucane F. F., Madans J. H., Brock D. B. Mortality among diabetics in a national sample. Am J Epidemiol. 1988 Aug;128(2):389–401. doi: 10.1093/oxfordjournals.aje.a114979. [DOI] [PubMed] [Google Scholar]
  19. Laakso M., Rönnemaa T., Pyörälä K., Kallio V., Puukka P., Penttilä I. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care. 1988 Jun;11(6):449–463. doi: 10.2337/diacare.11.6.449. [DOI] [PubMed] [Google Scholar]
  20. Ohlson L. O., Larsson B., Eriksson H., Svärdsudd K., Welin L., Tibblin G. Diabetes mellitus in Swedish middle-aged men. The study of men born in 1913 and 1923. Diabetologia. 1987 Jun;30(6):386–393. doi: 10.1007/BF00292539. [DOI] [PubMed] [Google Scholar]
  21. Pan W. H., Cedres L. B., Liu K., Dyer A., Schoenberger J. A., Shekelle R. B., Stamler R., Smith D., Collette P., Stamler J. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol. 1986 Mar;123(3):504–516. doi: 10.1093/oxfordjournals.aje.a114266. [DOI] [PubMed] [Google Scholar]
  22. Rosengren A., Wedel H., Wilhelmsen L. Coronary heart disease and mortality in middle aged men from different occupational classes in Sweden. BMJ. 1988 Dec 10;297(6662):1497–1500. doi: 10.1136/bmj.297.6662.1497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rosengren A., Wilhelmsen L., Pennert K., Berglund G., Elmfeldt D. Alcoholic intemperance, coronary heart disease and mortality in middle-aged Swedish men. Acta Med Scand. 1987;222(3):201–213. doi: 10.1111/j.0954-6820.1987.tb10661.x. [DOI] [PubMed] [Google Scholar]
  24. Schonfeld G., Birge C., Miller J. P., Kessler G., Santiago J. Apolipoprotein B levels and altered lipoprotein composition in diabetes. Diabetes. 1974 Oct;23(10):827–834. doi: 10.2337/diab.23.10.827. [DOI] [PubMed] [Google Scholar]
  25. Uusitupa M., Siitonen O., Voutilainen E., Aro A., Hersio K., Pyörälä K., Penttilä I., Ehnholm C. Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels. Diabetes Care. 1986 Jan-Feb;9(1):17–22. doi: 10.2337/diacare.9.1.17. [DOI] [PubMed] [Google Scholar]
  26. Wilhelmsen L., Berglund G., Elmfeldt D., Tibblin G., Wedel H., Pennert K., Vedin A., Wilhelmsson C., Werkö L. The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J. 1986 Apr;7(4):279–288. doi: 10.1093/oxfordjournals.eurheartj.a062065. [DOI] [PubMed] [Google Scholar]
  27. Yano K., Kagan A., McGee D., Rhoads G. G. Glucose intolerance and nine-year mortality in Japanese men in Hawaii. Am J Med. 1982 Jan;72(1):71–80. doi: 10.1016/0002-9343(82)90580-0. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES